n-Butylphthalide (NBP) Softgel Capsules in Stroke Patients

Not yet recruiting

Phase 2 Results N/A

Summary of Purpose

This will be a randomized, double-blind, placebo-controlled, add-on to standard-of-care study with a primary objective to assess the safety of NBP treatment in patients with mild to moderate acute ischemic stroke. The secondary objectives include determination of PK profile and exploratory evaluation for the efficacy of NBP treatment in stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 April 2017.

1 Jun 2017 23 Aug 2016 1 Mar 2020 1 Jun 2020 1 Apr 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

See All